Financière de Tubize SA (TUB.BR)

EUR 138.8

(-0.86%)

Operating Expenses Summary of Financière de Tubize SA

  • Financière de Tubize SA's latest annual operating expenses in 2023 was 114.38 Thousand EUR , up 2263.59% from previous year.
  • Financière de Tubize SA's latest quarterly operating expenses in 2024 Q2 was 20.51 Thousand EUR , down 0.0% from previous quarter.
  • Financière de Tubize SA reported a annual operating expenses of -5287.00 EUR in annual operating expenses 2022, down -100.34% from previous year.
  • Financière de Tubize SA reported a annual operating expenses of 1.53 Million EUR in annual operating expenses 2021, down -31.79% from previous year.
  • Financière de Tubize SA reported a quarterly operating expenses of 900.65 Thousand EUR for 2023 Q4, down 0.0% from previous quarter.
  • Financière de Tubize SA reported a quarterly operating expenses of 258.38 Thousand EUR for 2023 Q2, down 0.0% from previous quarter.

Annual Operating Expenses Chart of Financière de Tubize SA (2023 - 2003)

Historical Annual Operating Expenses of Financière de Tubize SA (2023 - 2003)

Year Operating Expenses Operating Expenses Growth
2023 114.38 Thousand EUR 2263.59%
2022 -5287.00 EUR -100.34%
2021 1.53 Million EUR -31.79%
2020 2.24 Million EUR -99.21%
2019 284.88 Million EUR 29855.84%
2018 951 Thousand EUR 1.17%
2017 940 Thousand EUR 38.85%
2016 677 Thousand EUR 13.97%
2015 594 Thousand EUR -8.33%
2014 648 Thousand EUR -20.3%
2013 813 Thousand EUR 94.5%
2012 418 Thousand EUR 12.37%
2011 372 Thousand EUR 1.92%
2010 365 Thousand EUR -7.83%
2009 396 Thousand EUR 178.11%
2008 -507 Thousand EUR -397.06%
2007 -102 Thousand EUR -109.6%
2006 1.06 Million EUR -24.13%
2005 1.4 Million EUR 283.84%
2004 365 Thousand EUR -96.59%
2003 10.69 Million EUR 0.0%

Peer Operating Expenses Comparison of Financière de Tubize SA

Name Operating Expenses Operating Expenses Difference
ABIONYX Pharma SA 4.17 Million EUR 97.261%
ABIVAX Société Anonyme 127.37 Million EUR 99.91%
Adocia SA 15.62 Million EUR 99.268%
Aelis Farma SA 18.81 Million EUR 99.392%
Biophytis S.A. 14.33 Million EUR 99.202%
Advicenne S.A. 8.21 Million EUR 98.608%
genOway Société anonyme 16.73 Million EUR 99.317%
IntegraGen SA 5.35 Million EUR 97.863%
Medesis Pharma S.A. 1.56 Million EUR 92.689%
Neovacs S.A. 10.34 Million EUR 98.894%
NFL Biosciences SA 4.37 Million EUR 97.385%
Plant Advanced Technologies SA 2.76 Million EUR 95.863%
Quantum Genomics Société Anonyme 1.71 Million EUR 93.342%
Sensorion SA 27.05 Million EUR 99.577%
Theranexus Société Anonyme 3 Million EUR 96.193%
TME Pharma N.V. 5.49 Million EUR 97.919%
Valbiotis SA 9.86 Million EUR 98.841%
TheraVet SA 1.64 Million EUR 93.043%
Valerio Therapeutics Société anonyme 20.32 Million EUR 99.437%
argenx SE 1.34 Billion EUR 99.991%
BioSenic S.A. 7.58 Million EUR 98.492%
Celyad Oncology SA 8.49 Million EUR 98.653%
DBV Technologies S.A. 89.4 Million EUR 99.872%
Galapagos NV 327.98 Million EUR 99.965%
Genfit S.A. 54.8 Million EUR 99.791%
GeNeuro SA 14.35 Million EUR 99.203%
Hyloris Pharmaceuticals SA 17.98 Million EUR 99.364%
Innate Pharma S.A. 64.57 Million EUR 99.823%
Inventiva S.A. 120.18 Million EUR 99.905%
MaaT Pharma SA 21.59 Million EUR 99.47%
MedinCell S.A. 32.92 Million EUR 99.653%
Nanobiotix S.A. 58.92 Million EUR 99.806%
Onward Medical N.V. 20.64 Million EUR 99.446%
Oryzon Genomics S.A. 18.49 Million EUR 99.382%
OSE Immunotherapeutics SA 23.58 Million EUR 99.515%
Oxurion NV 12.21 Million EUR 99.063%
Pharming Group N.V. 204.24 Million EUR 99.944%
Poxel S.A. 28.76 Million EUR 99.602%
GenSight Biologics S.A. 32.66 Million EUR 99.65%
Transgene SA 31.23 Million EUR 99.634%
UCB SA 2.94 Billion EUR 99.996%
Valneva SE 134.92 Million EUR 99.915%
Vivoryon Therapeutics N.V. 24.69 Million EUR 99.537%